Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis
(2014) 51ST ERA-EDTA CONGRESS — Location: Amsterdam (31.May.2014)
Files
JayneetalPhase2RandomisedtrialoforalC5AreceptorantagonistCCX168inANCA-associatedrenalvasculitisNephrolDialTransplantabstract2014.pdf
Restricted Access - Adobe PDF
- 620.13 KB
Details
- Authors
- Affiliations
Citations
Jayne, D. R. W., Bruchfeld, A., Schaier, M., Ciechanowski, K., Harper, L., Jadoul, M., Segelmark, M., Selga, D., Szombati, I., Venning, M., Hamilton, P., Hugo, C., Van Daele, P. L. A., Viklicky, O., Potarca, A., Schall, T. J., & Bekker, P. (2014). Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis. Nephrology, Dialysis, Transplantation, 29(suppl 3), iii27. https://hdl.handle.net/2078.5/77176 (Original work published 2014)